Population vulnerability to COVID-19 in Europe: a burden of disease analysis.
Grant M A WyperRicardo AssunçãoSarah CuschieriBrecht DevleeschauwerEilidh FletcherJuanita A HaagsmaHenk B M HilderinkJane IdavainTina LesnikElena Von der LippeMarek MajdanMilena S MilicevicElena PallariJosé L PeñalvoSara M PiresDietrich PlaßJoão V SantosDiane L StocktonSofie Theresa ThomsenIan GrantPublished in: Archives of public health = Archives belges de sante publique (2020)
Routine estimates of population structures and non-fatal burden of disease measures can be usefully combined to create composite indicators of vulnerability for rapid assessments, in this case to severe health consequences from COVID-19. Countries with available results for sub-national regions within their country, or national burden of disease studies that also use sub-national levels for burden quantifications, should consider using non-fatal burden of disease estimates to estimate geographical vulnerability to COVID-19.